GASTRIC CANCER 润色咨询

Gastric Cancer

出版年份:1998 年文章数:1100 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2023-04-09 146afc57m84暂无昵称 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:分子;肿瘤;基础
    经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。
    编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。
    目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2024-01-22 ms5000001363351337 来自湖北省

    偏重的研究方向:肿瘤
    经验分享:请问一下这个期刊可以投稿综述吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2023-08-19 1240adaem89暂无昵称 来自四川省

    大家几天才变成with editor呀?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2022-08-10 cyfy1112@163.com

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~
    很有效率

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2022-11-04 ms6000000285996390

    请问certification form在哪里下载?它要求的参考文献格式是哪一种?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2020-02-18 148249d5m16暂无昵称

    打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表:
    你好,请问你的certification form 怎么填写的啊

    150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2019-05-09 120cc505m10(暂无昵称)

    它收纳肝癌相关的文章吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2022-05-15 cindichaw

    19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2022-01-08 ms6000000933123975

    大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:分子;肿瘤;基础<br>经验分享:一审一个多月,两个审稿人很专业,给了两个月时间 major revision。二审十天,minor revision 当天修回后三天accept。<br>编辑的效率非常高,submit后第二天就with editor,隔天就under review。非常不错的杂志,影响因子和声誉都在稳步上升。<br>目前发文量减少,还是以临床文章为主,缺乏优质的基础研究,希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向:肿瘤<br>经验分享:请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:6.20投稿,7.10意见回来,8.9日返回,8.10 收到acceptance email~审稿速度,和editor 的速度,意外的快……本来以为修回后,可能会等一段时间,结果,第二天早上就收到email~<br>很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载?它要求的参考文献格式是哪一种?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名<span class="quote">150****6011暂无昵称 2020-02-13 00:00:00 发表:<br>你好,请问你的certification form 怎么填写的啊</span>, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好,请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219835, encodeId=b18d1219835e8, content=19年有一个快废了的工作投过,外审后被拒,比较专业,指出了其中的硬伤,但时间倒不长。今年又有一个鸡肋的基础工作,有硕士生明年要毕业,估计投不了十分以上的,可能下半年再投一下这个,碰碰运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Sun May 15 21:25:30 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们,小麻瓜想问,这个杂志需不需要提供知情同意书哇,感谢。审稿快不快哇,着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好,请问你的certification form 怎么填写的啊<span class="quote">173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:<br>我都这个状态2个月了,怎么办</span>, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2020-02-13 1483b6d8m11暂无昵称

    你好,请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:
    我都这个状态2个月了,怎么办

    173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了,怎么办

    1

    展开1条回复
共69条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分